BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lunde K, Solheim S, Aakhus S, Arnesen H, Moum T, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Forfang K. Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial. Am Heart J 2007;154:710.e1-8. [PMID: 17892996 DOI: 10.1016/j.ahj.2007.07.003] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Jiang B, Yan L, Shamul JG, Hakun M, He X. Stem cell therapy of myocardial infarction: a promising opportunity in bioengineering. Adv Ther (Weinh) 2020;3:1900182. [PMID: 33665356 DOI: 10.1002/adtp.201900182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
2 Lu H, Xie C, Zhao YM, Chen FM. Translational research and therapeutic applications of stem cell transplantation in periodontal regenerative medicine. Cell Transplant 2013;22:205-29. [PMID: 23031442 DOI: 10.3727/096368912X656171] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
3 Davis D, Stewart D. Cell therapy for cardiac repair – bench to bedside and back. Cardiac Regeneration and Repair. Elsevier; 2014. pp. 138-62. [DOI: 10.1533/9780857096708.2.138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Fisher SA, Zhang H, Doree C, Mathur A, Martin-rendon E; Cochrane Heart Group. Stem cell treatment for acute myocardial infarction. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd006536.pub4] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
5 Stamm C, Klose K, Choi YH. Clinical application of stem cells in the cardiovascular system. Adv Biochem Eng Biotechnol 2010;123:293-317. [PMID: 20803146 DOI: 10.1007/10_2010_77] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
6 Kao RL, Browder W, Li C. Cellular cardiomyoplasty: what have we learned? Asian Cardiovasc Thorac Ann 2009;17:89-101. [PMID: 19515892 DOI: 10.1177/0218492309104144] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
7 Esposito G, Dellegrottaglie S, Chiariello M. The extent of irreversible myocardial damage and the potential for left ventricular repair after primary percutaneous coronary intervention. Am Heart J 2010;160:S4-10. [PMID: 21147291 DOI: 10.1016/j.ahj.2010.10.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
8 Singh P, Williams DJ. Cell therapies: realizing the potential of this new dimension to medical therapeutics. J Tissue Eng Regen Med 2008;2:307-19. [DOI: 10.1002/term.108] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
9 Straburzyńska-migaj E, Popiel M, Grajek S, Katarzyńska-szymańska A, Lesiak M, Bręborowicz P, Sawiński K, Czyż A, Gil L, Kozłowska-skrzypczak M, Komarnicki M. Exercise capacity, arrhythmic risk profile, and pulmonary function is not influenced by intracoronary injection of Bone Marrow Stem Cells in patients with acute myocardial infarction. International Journal of Cardiology 2012;159:134-8. [DOI: 10.1016/j.ijcard.2011.02.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
10 Steinhoff G, Tiedemann G, Thalheimer M, Ho AD. [From basic research to the clinic. Regulations for preclinical and clinical studies with stem cells]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2008;51:973-9. [PMID: 18773175 DOI: 10.1007/s00103-008-0624-4] [Reference Citation Analysis]
11 Hua P, Wang YY, Liu LB, Liu JL, Liu JY, Yang YQ, Yang SR. In vivo magnetic resonance imaging tracking of transplanted superparamagnetic iron oxide-labeled bone marrow mesenchymal stem cells in rats with myocardial infarction. Mol Med Rep 2015;11:113-20. [PMID: 25323652 DOI: 10.3892/mmr.2014.2649] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
12 Jiang M, He B, Zhang Q, Ge H, Zang MH, Han ZH, Liu JP, Li JH, Zhang Q, Li HB. Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis. Expert Opin Biol Ther. 2010;10:667-680. [PMID: 20384520 DOI: 10.1517/14712591003716437] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
13 Jiang M, Pu J, He B. The short to mid-term effect of bone marrow derived cell transfer on diastolic function after acute myocardial infarction. International Journal of Cardiology 2011;153:87-8. [DOI: 10.1016/j.ijcard.2011.08.842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Xu S, Xu X, Guo Y, Gao W. Inflammatory responses after intracoronary mononuclear BM cell therapy in swine. Bone Marrow Transplant 2009;44:427-31. [DOI: 10.1038/bmt.2009.52] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
15 Kaminski A, Steinhoff G. Current Status of Intramyocardial Bone Marrow Stem Cell Transplantation. Seminars in Thoracic and Cardiovascular Surgery 2008;20:119-25. [DOI: 10.1053/j.semtcvs.2008.03.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
16 Tesche LJ, Gerber DA. Tissue-derived stem and progenitor cells. Stem Cells Int. 2010;2010:824876. [PMID: 21048854 DOI: 10.4061/2010/824876] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
17 Bøtker HE, Lassen TR, Jespersen NR. Clinical translation of myocardial conditioning. Am J Physiol Heart Circ Physiol 2018;314:H1225-52. [PMID: 29498531 DOI: 10.1152/ajpheart.00027.2018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
18 Stamm C, Nasseri B, Drews T, Hetzer R. Cardiac cell therapy: A realistic concept for elderly patients? Experimental Gerontology 2008;43:679-90. [DOI: 10.1016/j.exger.2008.05.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
19 Beliën H, Evens L, Hendrikx M, Bito V, Bronckaers A. Combining stem cells in myocardial infarction: The road to superior repair? Med Res Rev 2021. [PMID: 34114238 DOI: 10.1002/med.21839] [Reference Citation Analysis]
20 Eren P, Camus S, Matrone G, Ebrahimian TG, François D, Tedgui A, Sébastien Silvestre J, Blanc-brude OP. Adiponectinemia Controls Pro-Angiogenic Cell Therapy: Adiponectinemia Controls Pro-Angiogenic Cell Therapy. STEM CELLS 2009;27:2712-21. [DOI: 10.1002/stem.219] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
21 Mostafavian Z, Vakilian F, Torkmanzade L, Moghiman T. Effect of Stem Cell Therapy on Patients' Quality of Life in Heart Failure with Reduced Ejection Fraction. J Med Life 2018;11:359-64. [PMID: 30894895 DOI: 10.25122/jml-2018-0013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Arom KV, Ruengsakulrach P, Belkin M, Tiensuwan M. Intramyocardial Angiogenic Cell Precursors in Nonischemic Dilated Cardiomyopathy. Asian Cardiovasc Thorac Ann 2009;17:382-8. [DOI: 10.1177/0218492309338105] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
23 Fraccarollo D, Galuppo P, Bauersachs J. Novel therapeutic approaches to post-infarction remodelling. Cardiovasc Res 2012;94:293-303. [PMID: 22387461 DOI: 10.1093/cvr/cvs109] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 7.2] [Reference Citation Analysis]
24 Lie I, Arnesen H, Sandvik L, Hamilton G, Bunch EH. Predictors for physical and mental health 6 months after coronary artery bypass grafting: a cohort study. Eur J Cardiovasc Nurs 2010;9:238-43. [PMID: 20219433 DOI: 10.1016/j.ejcnurse.2010.02.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sadat K, Ather S, Aljaroudi W, Heo J, Iskandrian AE, Hage FG. The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion. J Nucl Cardiol. 2014;21:351-367. [PMID: 24379128 DOI: 10.1007/s12350-013-9846-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
26 Lyra AC, Soares MB, da Silva LF, Braga EL, Oliveira SA, Fortes MF, Silva AG, Brustolim D, Genser B, Dos Santos RR. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: A pilot randomized controlled study. Eur J Gastroenterol Hepatol. 2010;22 Suppl 1:33-42. [PMID: 19654548 DOI: 10.1097/meg.0b013e32832eb69a] [Cited by in Crossref: 74] [Cited by in F6Publishing: 33] [Article Influence: 6.7] [Reference Citation Analysis]
27 Davis DR, Stewart DJ. Autologous cell therapy for cardiac repair. Expert Opinion on Biological Therapy 2011;11:489-508. [DOI: 10.1517/14712598.2011.556615] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
28 Byun KH, Kim SW. Is stem cell-based therapy going on or out for cardiac disease? Korean Circ J 2009;39:87-92. [PMID: 19949592 DOI: 10.4070/kcj.2009.39.3.87] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
29 Silvestre JS, Smadja DM, Lévy BI. Postischemic revascularization: from cellular and molecular mechanisms to clinical applications. Physiol Rev 2013;93:1743-802. [PMID: 24137021 DOI: 10.1152/physrev.00006.2013] [Cited by in Crossref: 155] [Cited by in F6Publishing: 138] [Article Influence: 17.2] [Reference Citation Analysis]
30 Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature. 2008;453:322-329. [PMID: 18480813 DOI: 10.1038/nature07040] [Cited by in Crossref: 409] [Cited by in F6Publishing: 362] [Article Influence: 29.2] [Reference Citation Analysis]
31 Martin-Rendon E, Snowden JA, Watt SM. Stem cell-related therapies for vascular diseases. Transfus Med 2009;19:159-71. [PMID: 19706133 DOI: 10.1111/j.1365-3148.2009.00926.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
32 Jiang M, Mao J, He B. The effect of bone marrow-derived cells on diastolic function and exercise capacity in patients after acute myocardial infarction. Stem Cell Res. 2012;9:49-57. [PMID: 22640927 DOI: 10.1016/j.scr.2012.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
33 Brunskill SJ, Hyde CJ, Doree CJ, Watt SM, Martin-Rendon E. Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease. Eur J Heart Fail 2009;11:887-96. [PMID: 19654139 DOI: 10.1093/eurjhf/hfp101] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
34 Fujita T, Sakaguchi T, Miyagawa S, Saito A, Sekiya N, Izutani H, Sawa Y. Clinical impact of combined transplantation of autologous skeletal myoblasts and bone marrow mononuclear cells in patients with severely deteriorated ischemic cardiomyopathy. Surg Today 2011;41:1029-36. [PMID: 21773889 DOI: 10.1007/s00595-010-4526-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
35 Reffelmann T, Kloner RA. Intracoronary blood- or bone marrow-derived cell transplantation in patients with ischemic heart disease. Regenerative Medicine 2009;4:709-19. [DOI: 10.2217/rme.09.42] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
36 Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J. 2008;29:1807-1818. [PMID: 18523058 DOI: 10.1093/eurheartj/ehn220] [Cited by in Crossref: 385] [Cited by in F6Publishing: 322] [Article Influence: 27.5] [Reference Citation Analysis]
37 Yang Z, Zhang F, Ma W, Chen B, Zhou F, Xu Z, Zhang Y, Zhang D, Zhu T, Wang L. A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery. Cardiovasc Ther. 2010;28:380-385. [PMID: 20337639 DOI: 10.1111/j.1755-5922.2009.00116.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
38 Stamm C, Nasseri B, Hetzer R. Clinical Cell Therapy for Heart Disease. In: Baharvand H, editor. Trends in Stem Cell Biology and Technology. Totowa: Humana Press; 2009. pp. 191-228. [DOI: 10.1007/978-1-60327-905-5_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
39 Arbab AS, Janic B, Haller J, Pawelczyk E, Liu W, Frank JA. In Vivo Cellular Imaging for Translational Medical Research. Curr Med Imaging Rev 2009;5:19-38. [PMID: 19768136 DOI: 10.2174/157340509787354697] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
40 Dorobantu M, Popa-Fotea NM, Popa M, Rusu I, Micheu MM. Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease. World J Stem Cells 2017; 9(12): 203-218 [PMID: 29321822 DOI: 10.4252/wjsc.v9.i12.203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
41 Mullenix PS, Huddleston SJ, Stojadinovic A, Trachiotis GD, Alexander EP. A new heart: somatic stem cells and myocardial regeneration. J Surg Oncol 2012;105:475-80. [PMID: 22441899 DOI: 10.1002/jso.23014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
42 Zeinaloo A, Zanjani KS, Bagheri MM, Mohyeddin-Bonab M, Monajemzadeh M, Arjmandnia MH. Intracoronary administration of autologous mesenchymal stem cells in a critically ill patient with dilated cardiomyopathy. Pediatr Transplant. 2011;15:E183-E186. [PMID: 20880092 DOI: 10.1111/j.1399-3046.2010.01366.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]